topic

System analysis based on the cancer–immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma
Xu Wang, Tao Zhou, Xingyi Chen, Yu Wang, Yushi Ding, Haoyang Tu, Shengyang Gao, Haoyu Wang, Xinying Tang, Yong Yang

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004414; DOI: 10.1136/jitc-2021-004414
Correction: Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1
Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003224corr1; DOI: 10.1136/jitc-2021-003224corr1
Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma
Robert J Motzer, Toni K Choueiri, David F McDermott, Thomas Powles, Yann-Alexandre Vano, Saurabh Gupta, Jin Yao, Celine Han, Ron Ammar, Simon Papillon-Cavanagh, Shruti S Saggi, M Brent McHenry, Petra Ross-Macdonald, Megan Wind-Rotolo

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004316; DOI: 10.1136/jitc-2021-004316
Correction: Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e001931corr2; DOI: 10.1136/jitc-2020-001931corr2
Correction: PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e002500corr1; DOI: 10.1136/jitc-2021-002500corr1
Correction: Chemical augmentation of mitochondrial electron transport chains tunes T cell activation threshold in tumors
Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003958corr1; DOI: 10.1136/jitc-2021-003958corr1
Correction: MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy
Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e002029corr1; DOI: 10.1136/jitc-2020-002029corr1
The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation
Eva Sum, Moritz Rapp, Harald Dürr, Alekhya Mazumdar, Pedro J Romero, Christine Trumpfheller, Pablo Umaña

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e003264; DOI: 10.1136/jitc-2021-003264
Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer
Theodoros Michelakos, Filippos Kontos, Tomohiro Kurokawa, Lei Cai, Ananthan Sadagopan, Danielle Krijgsman, Wilko Weichert, Lindy G Durrant, Peter J K Kuppen, Cristina R Ferrone, Soldano Ferrone

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004115; DOI: 10.1136/jitc-2021-004115
C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer
Niklas Klümper, Jonas Saal, Fiamma Berner, Christa Lichtensteiger, Nina Wyss, Annkristin Heine, Franz Georg Bauernfeind, Jörg Ellinger, Peter Brossart, Stefan Diem, Sabine Schmid, Markus Joerger, Martin Frueh, Manuel Ritter, Michael Hölzel, Lukas Flatz, Tobias Bald

Journal for ImmunoTherapy of Cancer Mar 2022, 10 (3) e004024; DOI: 10.1136/jitc-2021-004024

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages